Target intelligence / Profile preview

Chloride channel accessory 3 pseudogene (CLCA3P)

Target
CLCA3P
Molecular classification
Pseudogene, Calcium-sensitive chloride conductance protein family
01

Overview

Chloride channel accessory 3 pseudogene (CLCA3P) is a transcribed pseudogene belonging to the calcium-sensitive chloride conductance protein family[3][4][8]. In humans, the transcript contains several nonsense codons, making it subject to nonsense-mediated mRNA decay and it is not believed to encode a functional protein[1][3][8]. While proteins in this family can be functional in other species (such as mice), and CLCA3 homologues participate in the regulation of chloride ion transport and may contribute to mucus secretion in goblet cells, the human CLCA3P is likely a non-functional processed pseudogene and not considered a therapeutic target in humans[1][2][3][4]. Most references indicate that it does not produce a protein in humans, though some older or less-confirmed reports suggest the possibility of expression, but this remains unverified[1][2]. As such, the gene has no established drug interactions, mechanisms of action, biomarker roles, or relevance for safety assessment in drug development.

Other names
CLCA3chloride channel accessory 3chloride channel, calcium activated, family member 3chloride channel regulator 3 pseudogene
02

Biological functions

Other (putative or unclear in human)may be involved in regulation of ion transport in non-human species[1][2][3]
03

Disease associations

Other (no clear role in human disease; in mice, may be linked to airway mucus regulation and inflammation[2])

Beyond the preview

Go deeper on Chloride channel accessory 3 pseudogene (CLCA3P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Chloride channel accessory 3 pseudogene (CLCA3P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call